LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

Search

Odonate Therapeutics Inc

Închisă

0

Rezumat

Modificarea prețului

24h

Curent

Minim

Maxim

Indicatori cheie

By Trading Economics

Odonate Therapeutics Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

4 mar. 2026, 23:39 UTC

Acțiuni populare

Stocks to Watch: Broadcom, StubHub, PepGen, Veeva Systems

4 mar. 2026, 23:20 UTC

Câștiguri

Broadcom Sales Rise as AI Developers Build More Products and Agents -- Update

4 mar. 2026, 21:43 UTC

Câștiguri

Broadcom Logs Higher Sales, Authorizes $10 Billion Buyback Amid Climbing AI Demand

4 mar. 2026, 23:48 UTC

Market Talk

Nikkei May Rise After Recent Selloffs -- Market Talk

4 mar. 2026, 23:33 UTC

Market Talk
Evenimente importante

Gold Edges Higher Amid Ongoing U.S.-Iran Conflict -- Market Talk

4 mar. 2026, 23:24 UTC

Market Talk

RBA on Track to Raise Rates, but What's the Rush? -- Market Talk

4 mar. 2026, 22:30 UTC

Câștiguri

Ecopetrol: Distribution Equivalent to a Payout of 50.1% of Ecopetrol S.A.'s Net Income in 2025 >EC

4 mar. 2026, 22:30 UTC

Câștiguri

Ecopetrol: Payment of Dividends Proposed to Be Made No Later Than April 30 >EC

4 mar. 2026, 22:30 UTC

Câștiguri

Ecopetrol: Earnings Distribution Proposes Ordinary Div Distribution of COP110 per Shr >EC

4 mar. 2026, 22:13 UTC

Câștiguri

Vermilion Energy: Expects Full-Yr Production of 118,000 to 122,000 Boe/d (70% Natural Gas) >VET

4 mar. 2026, 22:13 UTC

Câștiguri

Vermilion Energy: Expects 1Q Production to Avg 122,000 to 124,000 Boe/d (70% Natural Gas) >VET

4 mar. 2026, 22:13 UTC

Câștiguri

Vermilion Energy 4Q EPS C$2.86 >VET

4 mar. 2026, 22:04 UTC

Market Talk

RBA Slipping Behind The Curve On Rates -- Market Talk

4 mar. 2026, 21:53 UTC

Câștiguri

Lithium Americas 4Q Rev $66.8M >LAC

4 mar. 2026, 21:53 UTC

Câștiguri

Lithium Americas 4Q Loss/Shr 52c >LAC

4 mar. 2026, 21:52 UTC

Câștiguri

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4 mar. 2026, 21:50 UTC

Câștiguri

These Stocks Are Today's Movers: Moderna, Coinbase, Strategy, CoreWeave, Micron, Sandisk, GitLab, and More -- Barrons.com

4 mar. 2026, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

4 mar. 2026, 21:48 UTC

Câștiguri

Webull 4Q Rev $165.2M >BULL

4 mar. 2026, 21:48 UTC

Câștiguri

Webull 4Q EPS 1c >BULL

4 mar. 2026, 21:45 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

4 mar. 2026, 21:45 UTC

Market Talk

Canada Officials Might Need to Intervene to Spur Home Building -- Market Talk

4 mar. 2026, 21:40 UTC

Câștiguri

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4 mar. 2026, 21:36 UTC

Evenimente importante

Iran Conflict Spurs Rebound in U.S. Borrowing Costs -- Update

4 mar. 2026, 21:27 UTC

Câștiguri

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4 mar. 2026, 21:17 UTC

Market Talk

Energy Price Volatility Boosts Case for Climate-Tech Startups -- Market Talk

4 mar. 2026, 21:16 UTC

Câștiguri

Broadcom: Board Authorizes Share-Repurchase Program for Up to $10B of Common Stock >AVGO

4 mar. 2026, 21:15 UTC

Câștiguri

Broadcom 1Q EPS $1.50 >AVGO

4 mar. 2026, 21:15 UTC

Câștiguri

Broadcom 1Q Net $7.35B >AVGO

4 mar. 2026, 21:15 UTC

Câștiguri

Broadcom 1Q Rev $19.31B >AVGO

Comparație

Modificare preț

Odonate Therapeutics Inc Așteptări

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

EBITDA

Profit operațional

$

Despre Odonate Therapeutics Inc

Odonate, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was formerly known as Odonate Therapeutics, Inc. and changed its name to Odonate, Inc. in March 2023. The company was founded in 2013 and is based in New York, New York.
help-icon Live chat